the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression

Inclusion Criteria: * Age 6 to 12 years * Subjects and their guardians agreed to participate in this study * Best-corrected visual acuity (BCVA) 0.1 (log minimum angle of resolution, LogMAR) or better. * Initial NITM (spherical equivalent) ≤ -0.25 D * Cycloplegic refractions ≥ -1.0 D and astigmatism ≤ 2.5 D in both eyes. * Anisometropia in both eyes ≤ 1.5 D Exclusion Criteria: * Children with existing systemic diseases including asthma, collagen disease, immune system disorders, prostate hypertrophy, spastic paralysis, Down's syndrome, severe cardiac, pulmonary, hepatic, and renal dysfunction. * Patients with glaucoma or high intraocular pressure, ocular inflammatory diseases, strabismus, amblyopia, corneal diseases, diseases of lens, retinal and optic neuropathy * Regular use of medications that may affect the efficacy of 0.01% atropine, including hairy fruit rutabaga eye drops, tropicamide eye drops, anticholinergic drugs such as pirenzepine and tropicamide, and cholinergic drugs such as carbachol and hairy fruit rutabaga. * Previous experiences with myopia control therapy. * A history of allergies to atropine. * Patients were deemed inappropriate for trial participation by the lead investigator.